Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium
Go back to Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium| (NASDAQ: SPRB) | Delayed: 52.14 -2.56 (4.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.70 | 52 Week High | $ | |||
| Open | $53.49 | 52 Week Low | $ | |||
| Day High | $55.10 | P/E | N/A | |||
| Day Low | $52.14 | EPS | $ | |||
| Volume | 53,260 | |||||
